{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001785530","name":"Werewolf Therapeutics, Inc.","summary":"Werewolf Therapeutics is a biopharmaceutical company developing conditionally activated immunotherapies for cancer and immune-mediated conditions using its proprietary PREDATOR platform. Key products include WTX-124 (IL-2 INDUKINE) and WTX-330 (IL-12 INDUKINE) in clinical trials for solid tumors, plus preclinical INDUCER T cell engager molecules (WTX-1011, WTX-2022). In February 2026, the company adopted a restructuring plan and initiated a strategic alternatives review process.","people":[],"products":[{"name":"WTX-124","type":"platform","description":"Systemically delivered, conditionally activated IL-2 INDUKINE molecule in Phase 1/1b trial for advanced or metastatic solid tumors."},{"name":"WTX-330","type":"platform","description":"Systemically delivered, conditionally activated IL-12 INDUKINE molecule in Phase 1b/2 trial for advanced or metastatic solid tumors."},{"name":"WTX-712","type":"platform","description":"Conditionally activated IL-21 INDUKINE molecule in preclinical development for refractory and immunologically unresponsive tumors."},{"name":"WTX-518","type":"platform","description":"Conditionally activated IL-18 INDUKINE molecule in preclinical development for cancer treatment."},{"name":"WTX-921","type":"platform","description":"Conditionally activated IL-10 INDUKINE molecule in preclinical development for inflammatory bowel disease and other inflammatory diseases."},{"name":"WTX-1011","type":"platform","description":"INDUCER T cell engager molecule targeting STEAP1 tumor associated antigen in preclinical development."},{"name":"WTX-2022","type":"platform","description":"INDUCER T cell engager molecule targeting CDH6 tumor associated antigen in preclinical development."},{"name":"PREDATOR Platform","type":"platform","description":"Proprietary protein engineering platform designing conditionally activated INDUKINE and INDUCER molecules that selectively activate in the tumor microenvironment."}],"partnerships":[{"partner_name":"Merck & Co., Inc.","partnership_type":"development","description":"Collaboration to evaluate WTX-124 in combination with anti-PD-1 therapy KEYTRUDA (pembrolizumab) in Phase 1/1b clinical trial.","start_date":null},{"partner_name":"Jazz Pharmaceuticals Ireland Limited","partnership_type":"licensing","description":"Worldwide license to develop and commercialize JZP898 (formerly WTX-613), a conditionally activated IFN-alpha INDUKINE molecule.","start_date":null},{"partner_name":"Piper Sandler & Co.","partnership_type":"strategic","description":"Engaged as exclusive financial advisor to assist in strategic alternatives review process initiated in February 2026.","start_date":null}],"affiliations":[],"origin":{"leaf":"45b29962462c01e62d79256312f39a705b6715e2c75fb4b3adedf610e35a84e2","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"44e81ebf0e4ab664ae52d7f8c13ba50d566471925cef73a152e17293de953e99","parent":"4aad2fdb150fe9ef4b601f734578492ab7af8304a7f0d0467a6eb0fde569dfe2","source":"0001785530-26-000006","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":5,"hourly_limit":500,"remaining":495,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}